Labcorp director gains 897 shares from RSU vesting

Labcorp Holdings director Garheng Kong reported acquiring shares through the vesting and conversion of restricted stock units.

Rhea-AI Filing Summary

Labcorp Holdings director Garheng Kong reported acquiring shares through the vesting and conversion of restricted stock units. On February 11, 2026, 897 Restricted Stock Units converted into 897 shares of common stock at an exercise price of $0 per share.

Each Restricted Stock Unit represents the right to receive one Labcorp common share. After this transaction, Kong directly holds 13,739 shares of common stock and 773 Restricted Stock Units, which reflects the remaining aggregate RSU balance.

Insider Trade Summary

897 shares exercised/converted

Exercise 2 txns

Insider Kong Garheng

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	897	$0.00	$0.00
Exercise	Common Stock	897	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 773 contracts (Direct); Common Stock — 13,739 shares (Direct)

Footnotes (3)

1. F1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
2. F2. The Restricted Stock Units vested fully on February 11, 2026.
3. F3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Labcorp (LH) director Garheng Kong report?

Director Garheng Kong reported an acquisition via equity compensation. On February 11, 2026, 897 Restricted Stock Units were exercised and converted into 897 shares of Labcorp common stock at an exercise price of $0 per share, increasing his direct share holdings.

How many Labcorp (LH) shares does Garheng Kong own after this Form 4?

After the reported transaction, Garheng Kong directly holds 13,739 shares of Labcorp common stock. This total reflects the addition of 897 shares received from the conversion of vested Restricted Stock Units on February 11, 2026, as disclosed in the Form 4 filing.

What happened to Garheng Kong’s Restricted Stock Units in Labcorp (LH)?

A block of Garheng Kong’s Labcorp Restricted Stock Units vested and converted. On February 11, 2026, 897 RSUs vested fully and were exchanged for 897 common shares, leaving him with an aggregate remaining balance of 773 Restricted Stock Units after the transaction.

At what price were the Labcorp (LH) Restricted Stock Units exercised?

The Restricted Stock Units were exercised at an exercise price of $0 per share. This reflects typical equity compensation mechanics where vested RSUs convert into common stock without additional cash payment from the director upon settlement on February 11, 2026.

What does each Labcorp (LH) Restricted Stock Unit represent for Garheng Kong?

Each Labcorp Restricted Stock Unit represents the contingent right to receive one share of Labcorp common stock. When the RSUs vest, as they did on February 11, 2026, they convert into an equivalent number of common shares reported as acquired in the Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 12:53 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kong Garheng

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		M		897	A	(1)	13,739	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/11/2026		M			897	(2)	(2)	Common Stock	897	$0	773(3)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. The Restricted Stock Units vested fully on February 11, 2026.

3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Garheng Kong	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.